Patents by Inventor Vishweshwar Peddy
Vishweshwar Peddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220259209Abstract: The present invention relates to crystalline abrocitinib characterized by X-ray powder diffraction (XRPD) spectrum having peak reflections at about 12.9, 14.7, 19.4, 23.2 and 25.2±0.2 degrees 2 theta, and process for its preparation. The present invention relates to amorphous solid dispersion comprising abrocitinib or salt thereof together with at least one pharmaceutically acceptable carrier and process for its preparation.Type: ApplicationFiled: June 16, 2020Publication date: August 18, 2022Inventors: Shekhar Bhaskar Bhirud, Suresh Mahadev Kadam, Sachin Baban Gavhane, Vishweshwar Peddy, Shailendra Nilkanth Bhadane, Vinayak Kacheshwar Bhujade
-
Patent number: 11292793Abstract: The present application relates to solid state forms of Lumateperone p-Tosylate and processes for preparation thereof. The present application provides amorphous Lumateperone p-tosylate and a solid dispersion comprising amorphous Lumateperone p-tosylate and one or more pharmaceutically acceptable polymers and processes for preparation thereof. The compounds are useful as 5-HT2 receptor agonists and antagonists used in treating disorders of the central nervous system including a disorder associated with 5HT2C or 5HT2A receptor modulation.Type: GrantFiled: April 9, 2018Date of Patent: April 5, 2022Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Vishweshwar Peddy, Raja Sekhar Voguri
-
Patent number: 11168057Abstract: The present invention provides crystalline Roxadustat Form-?, crystalline Roxadustat Form-?, process for the preparation of crystalline Roxadustat Form-?, crystalline Roxadustat Form-? and its pharmaceutical compositions thereof. The present invention also provides co-crystals of Roxadustat Form RLP, Roxadustat Form RNM and Roxadustat Form RU, process for their preparation and pharmaceutical composition thereof.Type: GrantFiled: August 10, 2018Date of Patent: November 9, 2021Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Divya Jyothi Kallem, Rajesh Thipparaboina, Deepika Pathivada, Vishweshwar Peddy, Shanmukha Prasad Gopi
-
Patent number: 11084791Abstract: The present invention provides a crystalline form of Lenvatinib Mesylate, processes for the preparation of crystalline form of lenvatinib Mesylate and pharmaceutical compositions thereof. The crystalline form of lenvatinib Mesylate designated as Form VN1 is characterized by powder X-ray diffraction pattern. The present invention further provides a process for the preparation of amorphous form of lenvatinib Mesylate. The amorphous form is characterized by powder X-ray diffraction pattern.Type: GrantFiled: December 29, 2017Date of Patent: August 10, 2021Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Saladi Venkata Narasayya, Vamsi Krishna Mudapaka, Vishweshwar Peddy
-
Patent number: 11034675Abstract: Aspects of the present application relate to solid forms of Selinexor, processes for their preparation and pharmaceutical compositions thereof. Specific aspects relate to crystalline and amorphous forms of Selinexor.Type: GrantFiled: January 6, 2017Date of Patent: June 15, 2021Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Ramanaiah Chennuru, Satarupa Bhattacharjee, Srinivas Oruganti, Vishnu Vardhana Verna Reddy Eda, Ramesh Chakka, Vishweshwar Peddy, Srividya Ramakrishnan, Vamsi Krishna Mudapaka
-
Patent number: 10717740Abstract: The present application relates to crystalline propylene glycol solvate of acalabrutinib and process for preparation thereof. The propylene glycol solvate of acalabrutinib may be selected from a group of racemic propylene glycol solvate, R-propylene glycol solvate and S-propylene glycol solvate of acalabrutinib. Specifically, the present application relates to crystalline forms RSV1, RSV2, RSV3 and RSV4 of acalabrutinib. Crystalline forms RSV2 and RSV3 are stable in all conditions and has excellent physico-chemical properties. The present application also relates to crystalline form RSVS of acalabrutinib.Type: GrantFiled: June 8, 2018Date of Patent: July 21, 2020Assignee: DR. REDDY'S LABORATORIES LIMITED.Inventors: Raja Sekhar Voguri, Vishweshwar Peddy
-
Patent number: 10011590Abstract: The present application relates to crystalline and amorphous Vilazodone hydrochloride. The present application further relates to amorphous solid dispersions of vilazodone hydrochloride with pharmaceutically acceptable carriers. The present application also relates to a process for the preparation of form I of vilazodone free base.Type: GrantFiled: April 13, 2017Date of Patent: July 3, 2018Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Javed Iqbal, Srinivas Oruganti, Rajesh Kumar Rapolu, Vishweshwar Peddy, Rajesham Boge, Deepika Pathivada, Dharma Jagannadha Rao Velaga, Sesha Reddy Yarraguntla, Sudhakar Reddy Baddam, Anitha Naredla, Kiran Kumar Doniparthi, Srividya Ramakrishnan
-
Patent number: 9981947Abstract: Crystalline Forms R5, R5a, R5b and R6 of nilotinib hydrochloride and processes for their preparation.Type: GrantFiled: January 10, 2017Date of Patent: May 29, 2018Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Vishweshwar Peddy, Ramanaiah Chennuru, Srividya Ramakrishnan
-
Patent number: 9701641Abstract: The present application relates to crystalline and amorphous forms of Enzalutamide. The present application further relates to amorphous solid dispersions of Enzalutamide with pharmaceutically acceptable carriers. The present application also relates to a process for the preparation of Form R1 of Enzalutamide.Type: GrantFiled: October 13, 2016Date of Patent: July 11, 2017Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Vishweshwar Peddy, Rajesham Boge, Lokeswara Rao Madivada
-
Patent number: 9655885Abstract: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of ? form crystal and ? form crystal of mirabegron and pharmaceutical composition thereof.Type: GrantFiled: April 21, 2015Date of Patent: May 23, 2017Assignee: DR. REDDY'S LABORATORIES LTD.Inventors: Vishweshwar Peddy, Rajesham Boge, Yogesh S Gattani, Nagoji Shinde, Pradip Kumar Ghosh, Sritharan Seetharaman, Navin Vaya, Vaibhav Sihorkar, Rajashekhar Totad, Krishna Venkatesh, Ganesh Arun Katkar, Snehalatha Movva, Piyush Chudiwal
-
Patent number: 9580408Abstract: Crystalline Forms R5, R5a, R5b and R6 of nilotinib hydrochloride and processes for their preparation.Type: GrantFiled: April 23, 2014Date of Patent: February 28, 2017Assignee: DR. REDDY'S LABORATORIES LIMITEDInventors: Vishweshwar Peddy, Ramanaiah Chennuru, Srividya Ramakrishnan
-
Patent number: 9283210Abstract: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of a form crystal and ? form crystal of mirabegron and pharmaceutical composition thereof.Type: GrantFiled: May 17, 2012Date of Patent: March 15, 2016Assignee: DR. REDDY'S LABORATORIES LTD.Inventors: Vishweshwar Peddy, Rajesham Boge
-
Publication number: 20150239848Abstract: The present application relates to crystalline and amorphous forms of Enzalutamide. The present application further relates to amorphous solid dispersions of Enzalutamide with pharmaceutically acceptable carriers. The present application also relates to a process for the preparation of Form R1 of Enzalutamide.Type: ApplicationFiled: September 11, 2013Publication date: August 27, 2015Inventors: Vishweshwar Peddy, Rajesham Boge, Lokeswara Rao Madivada
-
Publication number: 20150126525Abstract: Provided are crystalline and amorphous vilazodone hydrochloride. Further provided are amorphous solid dispersions of vilazodone hydrochloride with pharmaceutically acceptable carries. Also provided is a process for the preparation of form I of vilazodone free base.Type: ApplicationFiled: May 10, 2013Publication date: May 7, 2015Inventors: Javed Iqbal, Srinivas Oruganti, Rajesh Kumar Rapolu, Vishweshwar Peddy, Rajesham Boge, Deepika Pathivada, Dharma Jagannadha Rao Velaga, Sesha Reddy Yarraguntla, Sudhakar Reddy Baddam, Anitha Naredla, Kiran Kumar Doniparthi, Ramesh Kumar Nadgoud, Narasimha Rao Pagadala, Syam Kumar Unniaran, Srividya Ramakrishnan
-
Publication number: 20140206729Abstract: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of a form crystal and ? form crystal of mirabegron and pharmaceutical composition thereof.Type: ApplicationFiled: May 17, 2012Publication date: July 24, 2014Applicant: DR. REDDY'S LABORATORIES LIMITEDInventors: Vishweshwar Peddy, Rajesham Boge
-
Publication number: 20140187538Abstract: The present invention relates to amorphous lorcaserin hydrochloride; amorphous solid dispersion comprising lorcaserin hydrochloride and one or more pharmaceutically acceptable carries; processes for preparation thereof; pharmaceutical compositions comprising amorphous lorcaserin hydrochloride and one or more pharmaceutically acceptable carries.Type: ApplicationFiled: December 26, 2013Publication date: July 3, 2014Applicant: DR. REDDY'S LABORATORIES LTD.Inventors: Rajesham Boge, Arjun Kumar Tummala, Vishweshwar Peddy, Srinivasulu Rangineni, Vilas Hareshwar Dahanukar, Bandichhor Rakeshwar, Areveli Srinivas, Macharla Prabhakar, Varanasi Ganesh
-
Publication number: 20100331285Abstract: A polymorph of aspirin is provided by the present invention. Methods of making and using the same are also provided.Type: ApplicationFiled: August 23, 2010Publication date: December 30, 2010Applicants: TRANSFORM PHARMACEUTICALS, INC., UNIVERSITY OF SOUTH FLORIDAInventors: Orn Almarsson, Jennifer McMahon, Vishweshwar Peddy, Matthew Peterson, Michael J. Zaworotko
-
Publication number: 20080319068Abstract: A polymer of aspirin is provided by the present invention. Methods of making and using the same are also provided.Type: ApplicationFiled: April 25, 2006Publication date: December 25, 2008Applicants: Transform Pharmaceuticals, Inc., University of South FloridaInventors: Orn Almarsson, Jennifer McMahon, Vishweshwar Peddy, Matthew Peterson, Michael J. Zaworotko